News und Analysen
![Sprinklr: Has the smoke cleared to buy back in?: https://www.marketbeat.com/logos/articles/med_20240107110751_chart2-cxm.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOWNGYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7e37ebf2ef1857d804aae74a02dc3cd7d3c1b0be/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240107110751_chart2-cxm.jpg?locale=de)
Sprinklr: Has the smoke cleared to buy back in?
Sprinklr Inc. (NYSE: CXM) offers a cloud-based unified customer experience management (unified-CXM) platform. As a member of the business services sector, Sprinklr enables companies to manage all
![Sprinklr: Has the smoke cleared to buy back in?: https://www.marketbeat.com/logos/articles/med_20240107110751_chart2-cxm.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOWNGYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7e37ebf2ef1857d804aae74a02dc3cd7d3c1b0be/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240107110751_chart2-cxm.jpg?locale=de)
Sprinklr: Has the smoke cleared to buy back in?
Sprinklr Inc. (NYSE: CXM) offers a cloud-based unified customer experience management (unified-CXM) platform. As a member of the business services sector, Sprinklr enables companies to manage all
![Sprinklr: Has the smoke cleared to buy back in?: https://www.marketbeat.com/logos/articles/med_20240107110751_chart2-cxm.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOWNGYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7e37ebf2ef1857d804aae74a02dc3cd7d3c1b0be/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240107110751_chart2-cxm.jpg?locale=de)
Sprinklr: Has the smoke cleared to buy back in?
Sprinklr Inc. (NYSE: CXM) offers a cloud-based unified customer experience management (unified-CXM) platform. As a member of the business services sector, Sprinklr enables companies to manage all
![Eilt: Hautkrebs vollständig geheilt - Ausbruch Massives Kaufsignal. Neuer 175% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73189/AC_Vidac_090124_DEPRcom.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNElGYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--df947e8d4455bad3ccec370fa46d3bfd6dc51e16/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC_Vidac_090124_DEPRcom.001.png?locale=de)
Eilt: Hautkrebs vollständig geheilt - Ausbruch Massives Kaufsignal. Neuer 175% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Massives Kaufsignal. Neuer 175% Biotech Aktientip nach 15973% mit BioNTech ($BNTX)
09.01.24 08:02
London (www.aktiencheck.de, Anzeige)
![Eilt: Hautkrebs vollständig geheilt - Ausbruch Massives Kaufsignal. Neuer 175% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73189/AC_Vidac_090124_DEPRcom.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNElGYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--df947e8d4455bad3ccec370fa46d3bfd6dc51e16/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC_Vidac_090124_DEPRcom.001.png?locale=de)
Eilt: Hautkrebs vollständig geheilt - Ausbruch Massives Kaufsignal. Neuer 175% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Massives Kaufsignal. Neuer 175% Biotech Aktientip nach 15973% mit BioNTech ($BNTX)
09.01.24 08:02
London (www.aktiencheck.de, Anzeige)
![Eilt: Hautkrebs vollständig geheilt - Ausbruch Massives Kaufsignal. Neuer 175% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73189/AC_Vidac_090124_DEPRcom.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNElGYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--df947e8d4455bad3ccec370fa46d3bfd6dc51e16/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC_Vidac_090124_DEPRcom.001.png?locale=de)
Eilt: Hautkrebs vollständig geheilt - Ausbruch Massives Kaufsignal. Neuer 175% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Massives Kaufsignal. Neuer 175% Biotech Aktientip nach 15973% mit BioNTech ($BNTX)
09.01.24 08:02
London (www.aktiencheck.de, Anzeige)
![Boeing stock gaps down 8.50% on new round of 737 Max woes: https://www.marketbeat.com/logos/articles/med_20240108114018_boeing-stock-gaps-down-8.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEVGYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3e4dd95399da04d1e723d232165b677270468035/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240108114018_boeing-stock-gaps-down-8.jpg?locale=de)
Boeing stock gaps down 8.50% on new round of 737 Max woes
Shares of The Boeing Co. (NYSE: BA) gapped down 8.50% at the open on January 8, after a panel from an Alaska Air Group Inc. (NYSE: ALK) fell out mid-flight.
The plane made an emergency landing
![Boeing stock gaps down 8.50% on new round of 737 Max woes: https://www.marketbeat.com/logos/articles/med_20240108114018_boeing-stock-gaps-down-8.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEVGYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3e4dd95399da04d1e723d232165b677270468035/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240108114018_boeing-stock-gaps-down-8.jpg?locale=de)
Boeing stock gaps down 8.50% on new round of 737 Max woes
Shares of The Boeing Co. (NYSE: BA) gapped down 8.50% at the open on January 8, after a panel from an Alaska Air Group Inc. (NYSE: ALK) fell out mid-flight.
The plane made an emergency landing
![Merck, the Dow's hottest stock, gets set to report Q4 financials: https://www.marketbeat.com/logos/articles/med_20240118082845_merck-the-dows-hottest-stock-gets-set-to-report-q4.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOHdQYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f0642dfc46452e6678ffb48d8df3cbbcd9a223c7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240118082845_merck-the-dows-hottest-stock-gets-set-to-report-q4.jpg?locale=de)
Merck, the Dow's hottest stock, gets set to report Q4 financials
Dow Jones Industrial Average (DJIA) stalwart Merck & Co., Inc. (NYSE:MRK) has momentum on its side heading into its February 1st earnings report.
Shares of the large cap pharmaceutical company
![Voyager Therapeutics stock pops 30% on deal with Novartis: https://www.marketbeat.com/logos/articles/med_20240108080612_voyager-therapeutics-pops-30-on-gene-therapy-deal.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOWdFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d6d8cf733f50b87149bec09f287b00c8d609fb8c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240108080612_voyager-therapeutics-pops-30-on-gene-therapy-deal.jpg?locale=de)
Voyager Therapeutics stock pops 30% on deal with Novartis
Voyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took a 30% spike on news of its partnership with
![Chipotle stock price can set a new all-time high in 2024: https://www.marketbeat.com/logos/articles/med_20240108074725_chart-cmg-182024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOWNFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--796f544990384649804d2684f40aab8355b3d976/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240108074725_chart-cmg-182024ver001.png?locale=de)
Chipotle stock price can set a new all-time high in 2024
Chipotle Mexican Grill (NYSE: CMG) shares entered correction along with the broader market at the start of 2024, but the pullback will not likely get far. The company continues to execute at the
![Spirit AeroSystems stock will rally on Boeing's new orders: https://www.marketbeat.com/logos/articles/med_20240108075454_spirit-aerosystems-stock-will-rally-on-boeings-new.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOWtFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--15db4a0fe1ec8d6ccd3db996b31ce946ab429322/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240108075454_spirit-aerosystems-stock-will-rally-on-boeings-new.jpg?locale=de)
Spirit AeroSystems stock will rally on Boeing's new orders
Everyone is focused on the popularity of following Boeing (NYSE: BA) and its recent development in new orders. After years of being compressed below any reasonable fairness, its stock is finally
![Spirit AeroSystems stock will rally on Boeing's new orders: https://www.marketbeat.com/logos/articles/med_20240108075454_spirit-aerosystems-stock-will-rally-on-boeings-new.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOWtFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--15db4a0fe1ec8d6ccd3db996b31ce946ab429322/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240108075454_spirit-aerosystems-stock-will-rally-on-boeings-new.jpg?locale=de)
Spirit AeroSystems stock will rally on Boeing's new orders
Everyone is focused on the popularity of following Boeing (NYSE: BA) and its recent development in new orders. After years of being compressed below any reasonable fairness, its stock is finally
![Apple stock at a crossroads, is now the time to buy?: https://www.marketbeat.com/logos/articles/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnNFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7873cbd614ac867322372363d0ec319a30d73bc9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg?locale=de)
Apple stock at a crossroads, is now the time to buy?
Apple Inc. (NASDAQ: AAPL) stands as a towering figure in the world of stocks and investments, a testament to the power of innovation and resilience in the tech industry. However, recent price
![Bank of America and Citigroup are banking stocks that could soar: https://www.marketbeat.com/logos/articles/med_20240108073632_bank-of-america-and-citigroup-are-banking-stocks-c.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNm9FYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ff0768e20c82f2be10c11cc0741e47d2704f772b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240108073632_bank-of-america-and-citigroup-are-banking-stocks-c.jpg?locale=de)
Bank of America and Citigroup are banking stocks that could soar
Who likes to invest in financial stocks? Only people with a solid financial or accounting background, since they can reasonably understand the balance sheets and valuations of these stocks well
![Apple stock at a crossroads, is now the time to buy?: https://www.marketbeat.com/logos/articles/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnNFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7873cbd614ac867322372363d0ec319a30d73bc9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg?locale=de)
Apple stock at a crossroads, is now the time to buy?
Apple Inc. (NASDAQ: AAPL) stands as a towering figure in the world of stocks and investments, a testament to the power of innovation and resilience in the tech industry. However, recent price
![Apple stock at a crossroads, is now the time to buy?: https://www.marketbeat.com/logos/articles/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnNFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7873cbd614ac867322372363d0ec319a30d73bc9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg?locale=de)
Apple stock at a crossroads, is now the time to buy?
Apple Inc. (NASDAQ: AAPL) stands as a towering figure in the world of stocks and investments, a testament to the power of innovation and resilience in the tech industry. However, recent price
![Apple stock at a crossroads, is now the time to buy?: https://www.marketbeat.com/logos/articles/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnNFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7873cbd614ac867322372363d0ec319a30d73bc9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg?locale=de)
Apple stock at a crossroads, is now the time to buy?
Apple Inc. (NASDAQ: AAPL) stands as a towering figure in the world of stocks and investments, a testament to the power of innovation and resilience in the tech industry. However, recent price
![2 low-priced gene therapy stocks to speculate on: https://www.marketbeat.com/logos/articles/med_20240107112838_chart-sgmo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNmtFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--69c93154321571d9fc40739a4b0f16bee8789fcc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240107112838_chart-sgmo.jpg?locale=de)
2 low-priced gene therapy stocks to speculate on
Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic differences. Gene-editing involves using
![2 low-priced gene therapy stocks to speculate on: https://www.marketbeat.com/logos/articles/med_20240107112838_chart-sgmo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNmtFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--69c93154321571d9fc40739a4b0f16bee8789fcc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240107112838_chart-sgmo.jpg?locale=de)
2 low-priced gene therapy stocks to speculate on
Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic differences. Gene-editing involves using
![Peloton Stock surges on TikTok deal...can it keep up the pace?: https://www.marketbeat.com/logos/articles/med_20240108071707_peloton-stock-surges-on-tiktok-deal.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNmNFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--879f3341c58b1e8652c41dd112a1155c3e7d3071/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240108071707_peloton-stock-surges-on-tiktok-deal.jpg?locale=de)
Peloton Stock surges on TikTok deal...can it keep up the pace?
In an attempt to revive its stagnant subscriber base, Peloton Interactive, Inc. (NASDAQ:PTON) is turning to TikTok.
Last week, the connected fitness company announced its own connection with the
![HCA Healthcare Rallies: Weight-loss drugs really a big threat?: https://www.marketbeat.com/logos/articles/med_20240107185912_hca-healthcare-rallies-weight-loss-drugs-really-a.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHdFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a18c6bc757c70846460135778d82539bb366e6b5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240107185912_hca-healthcare-rallies-weight-loss-drugs-really-a.jpg?locale=de)
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
Hospital chain HCA Healthcare, Inc. (NYSE: HCA) has been working on a bullish base and even managed to post gains in a week when the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) pulled back.
Investors
![3 Magnificent Seven stocks are approaching potential buy zones: https://www.marketbeat.com/logos/articles/med_20240107184322_3-magnificent-seven-stocks-are-approaching-potenti.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHNFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0e2719fed11d08985740ddfa0e2da1addf2c92e6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240107184322_3-magnificent-seven-stocks-are-approaching-potenti.jpg?locale=de)
3 Magnificent Seven stocks are approaching potential buy zones
As the year begins and capital begins to be put to work, a new chapter is unfolding for members of the heralded 'Magnificent Seven.' As the curtains rise in 2024, these tech behemoths, the guiding
![3 Magnificent Seven stocks are approaching potential buy zones: https://www.marketbeat.com/logos/articles/med_20240107184322_3-magnificent-seven-stocks-are-approaching-potenti.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHNFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0e2719fed11d08985740ddfa0e2da1addf2c92e6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240107184322_3-magnificent-seven-stocks-are-approaching-potenti.jpg?locale=de)
3 Magnificent Seven stocks are approaching potential buy zones
As the year begins and capital begins to be put to work, a new chapter is unfolding for members of the heralded 'Magnificent Seven.' As the curtains rise in 2024, these tech behemoths, the guiding
![3 Magnificent Seven stocks are approaching potential buy zones: https://www.marketbeat.com/logos/articles/med_20240107184322_3-magnificent-seven-stocks-are-approaching-potenti.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHNFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0e2719fed11d08985740ddfa0e2da1addf2c92e6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240107184322_3-magnificent-seven-stocks-are-approaching-potenti.jpg?locale=de)
3 Magnificent Seven stocks are approaching potential buy zones
As the year begins and capital begins to be put to work, a new chapter is unfolding for members of the heralded 'Magnificent Seven.' As the curtains rise in 2024, these tech behemoths, the guiding